Pfizer and BioNTech Seek Authorization of a Second Booster Shot for Older Americans. Vaccination and Immunization, Coronavirus (2019-nCoV), Research, BioNTech SE, Centers for Disease Control and Prevention, Food and Drug Administration, Pfizer Inc, National Institutes of Health, Elderly